Hologic acquires Suros Surgical Systems

8 August 2006

Bedford, Mass., USA. Hologic, Inc. (NASDAQ:HOLX), a manufacturer of diagnostic digital imaging systems for women's health, has completed the acquisition of Suros Surgical Systems, Inc., a manufacturer of devices used for minimally invasive breast biopsy and tissue excision.

"This acquisition is an important milestone in the execution of our overall strategy to grow our business and expand our presence in the women's health market," said Jack Cumming, Chairman and Chief Executive Officer. "We believe the increasing adoption of minimally invasive procedures, such as vacuum assisted breast biopsy, will improve patient safety, advance the quality of care and reduce costs. We look forward to the opportunities we see for future growth and success as Suros becomes a member of the Hologic family."

Suros Surgical Systems, Inc., located in Indianapolis, Indiana manufactures products for minimally invasive surgery, focused on breast biopsy and tissue removal. Suros Surgical's ATEC (automated tissue excision and collection) line of products, include percutaneous, automatic vacuum assisted breast biopsy systems, ancillary breast biopsy devices and biopsy site markers.

Under the terms of the agreement signed April 17, 2006, the purchase price for the transaction, exclusive of certain transaction costs and expenses, is approximately $240 million payable in approximately $135 million in cash and 2,330,000 shares of common stock. In addition, an earn-out will be payable in two annual cash installments equal to the incremental revenue growth in Suros Surgical's business in the two years following the closing.

"We are pleased we have finalized this agreement with Hologic," said Jim Pearson, President and CEO of Suros Surgical Systems, Inc. "We believe Hologic's industry presence and experience will facilitate getting the ATEC Breast Biopsy and Excision System in the hands of physicians, which will only benefit their patients worldwide."

To top